NCT06796894
Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
At risk: Primary completion moved 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 5 words Show 4 more changesShow less
- Primary completion pushed from Oct 30, 2026 to Mar 30, 2027
- Study completion pushed from Dec 1, 2026 to Apr 1, 2027
- Secondary endpoints: details revised at 5 of 9 entries
- Study description revised
- Notable Primary completion date: Oct 30, 2025 to Oct 30, 2026
- Study completion date: Dec 1, 2025 to Dec 1, 2026
- Notable Primary completion date: Mar 30, 2025 to Oct 30, 2025
- Study completion date: Apr 1, 2025 to Dec 1, 2025
- Notable Primary endpoints: 2 to 1
- Primary completion date: Feb 27, 2025 to Mar 30, 2025
- Secondary endpoints expanded, about 28 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Respiratory Symptoms
Timeframe: One day
Secondary (9)
Pulmonary functions
Dyspnea during daily life
Asthma Control Level
Fatigue level
Asthma and allergic rhinit symptoms
Show 4 moreShow less
Activities of daily living
Frailty
Disease spesific quality of life
Laboratory testing
Sites
1 site in 1 country
- Hacettepe UniversityAnkara, State, Turkey (Türkiye)